Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma

首次发布于 2012 年 9 月 21 日

Anti-OX40 Antibody in Head and Neck Cancer Patients

计划入组 17 人 · 首次发布于 2014 年 10 月 24 日

Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer

计划入组 13 人 · 首次发布于 2011 年 2 月 25 日

OX40-Ab

OX40 Mab (Immunoah)

OX40-Ab(Protheragen)

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Veru Inc

United States

FDA Clears IND Application for Novel Monoclonal Antibody OX40 Antagonist for Atopic Dermatitis

Kyowa Kirin to Present Phase 3 Rocatinlimab Results for Atopic Dermatitis at EADV 2025

Rocatinlimab Shows Promise in Phase 3 Trial for Moderate to Severe Atopic Dermatitis